iStent Inject New Enrollment Post-Approval Study

计划入组 358 人 · 首次发布于 2020 年 11 月 12 日

Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost

计划入组 196 人 · 首次发布于 2011 年 9 月 30 日

iStent Inject Trabecular Micro-Bypass System Continuation Post-Approval Study

计划入组 475 人 · 首次发布于 2020 年 11 月 12 日

Invert sugar

Rx

Patent Blue

C₂₇H₃₃N₂O₇S₂

ridaforolimus drug eluting stent

Glaukos Corporation

United States

Invent Medic Sweden AB

Sweden

SkinJect, Inc.

United States

Sight Sciences OMNI System Gains UnitedHealthcare Coverage as Meta-Analysis Confirms Long-Term Efficacy in Glaucoma Treatment

NIH Begins Clinical Trials for Twice-Yearly HIV Prevention Injection

Stanford Research Demonstrates Ultra-High Concentration Biologic Delivery via Subcutaneous Injection